To Improve Pain and Function, Platelet-Rich Plasma Injections May Be an Alternative to Surgery for Treating Lateral Epicondylitis: A Systematic Review.


Journal

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association
ISSN: 1526-3231
Titre abrégé: Arthroscopy
Pays: United States
ID NLM: 8506498

Informations de publication

Date de publication:
11 2021
Historique:
received: 23 09 2020
revised: 05 04 2021
accepted: 15 04 2021
pubmed: 7 5 2021
medline: 17 11 2021
entrez: 6 5 2021
Statut: ppublish

Résumé

To determine whether platelet-rich plasma (PRP) injection for lateral epicondylitis offers patients comparable outcomes to lateral epicondylar surgery. Embase, Cochrane Library, and MEDLINE databases were searched using the terms lateral epicondylitis, lateral elbow pain, tennis elbow, lateral epicondylalgia, and elbow tendinopathy individually and combined with the terms platelet-rich plasma injections and lateral epicondylar surgery. We compared pain relief, function between the 2 treatment options, and identified whether PRP injection reduced the incidence of lateral epicondylar surgery. Studies must have compared PRP injections with lateral epicondylar surgery for the treatment of lateral epicondylitis; be of Level I, II, or III evidence; and be written in the English language. Three studies (1 Level II and 2 Level III) met inclusion criteria. Two of the studies suggested that PRP injections offer similar relief as surgery in the short and mid-term, one study reported that PRP injections and surgery had similar outcomes in pain improvement and return to work, whereas 1 study reported that surgery may be a better long-term solution. In comparison with lateral epicondylar surgery, PRP injections offer similar improvements in pain and function for patients suffering from lateral epicondylitis, especially in the short- and mid-term in 2 of the 3 included investigations. Therefore, PRP injections are an appropriate alternative for the treatment of lateral epicondylitis. Level III, Systematic Review of Level III or greater evidence.

Identifiants

pubmed: 33957212
pii: S0749-8063(21)00435-7
doi: 10.1016/j.arthro.2021.04.043
pii:
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3360-3367

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Auteurs

Richard Hardy (R)

Heartland Orthopedic Specialists, Alexandria, Minnesota, U.S.A.. Electronic address: rhardy@heartlandorthopedics.com.

Aerika Tori (A)

University of Minnesota Morris, Morris, Minnesota, U.S.A.

Hannah Fuchs (H)

University of Minnesota Morris, Morris, Minnesota, U.S.A.

Taiyo Larson (T)

University of Minnesota Morris, Morris, Minnesota, U.S.A.

Jefferson Brand (J)

Heartland Orthopedic Specialists, Alexandria, Minnesota, U.S.A.

Emily Monroe (E)

Heartland Orthopedic Specialists, Alexandria, Minnesota, U.S.A.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH